Sugimoto, M.; Chujo, S.; Kato, K.; Shimura, M.; Kitano, S.; Kusuhara, S.; Terasaki, H.; Kondo, M.; Writing Committee of Japan-Clinical Retina Study Group (J-CREST).
Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents. J. Clin. Med. 2024, 13, 7336.
https://doi.org/10.3390/jcm13237336
AMA Style
Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, Terasaki H, Kondo M, Writing Committee of Japan-Clinical Retina Study Group (J-CREST).
Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents. Journal of Clinical Medicine. 2024; 13(23):7336.
https://doi.org/10.3390/jcm13237336
Chicago/Turabian Style
Sugimoto, Masahiko, Shinichiro Chujo, Kumiko Kato, Masahiko Shimura, Shigehiko Kitano, Sentaro Kusuhara, Hiroto Terasaki, Mineo Kondo, and Writing Committee of Japan-Clinical Retina Study Group (J-CREST).
2024. "Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents" Journal of Clinical Medicine 13, no. 23: 7336.
https://doi.org/10.3390/jcm13237336
APA Style
Sugimoto, M., Chujo, S., Kato, K., Shimura, M., Kitano, S., Kusuhara, S., Terasaki, H., Kondo, M., & Writing Committee of Japan-Clinical Retina Study Group (J-CREST).
(2024). Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents. Journal of Clinical Medicine, 13(23), 7336.
https://doi.org/10.3390/jcm13237336
